News >

Neoadjuvant Chemo Safer Alternative for Certain Patients With Ovarian Cancer

Kristi Rosa
Published: Wednesday, Aug 28, 2019

Linda R. Duska, MD, professor of obstetrics and gynecology, University of Virginia

Linda R. Duska, MD

Although upfront debulking surgery is standard for most patients with advanced ovarian cancer, neoadjuvant chemotherapy potentially offers a less morbid alternative for those who are ineligible for the procedure, said Linda R. Duska, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Oncology Briefings™: A Nurses' Guide to Managing Adverse Events Associated with PARP InhibitorsJun 30, 20201.0
Publication Bottom Border
Border Publication
x